| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glioblastoma | 20 | 2024 | 1774 | 2.240 |
Why?
|
| Glioma | 15 | 2022 | 1972 | 1.340 |
Why?
|
| Brain Neoplasms | 19 | 2024 | 4955 | 1.320 |
Why?
|
| PTEN Phosphohydrolase | 16 | 2017 | 1013 | 1.230 |
Why?
|
| Phosphoric Monoester Hydrolases | 11 | 2003 | 264 | 0.980 |
Why?
|
| Tumor Suppressor Proteins | 13 | 2021 | 1899 | 0.830 |
Why?
|
| Signal Transduction | 15 | 2019 | 12105 | 0.660 |
Why?
|
| Mice, Nude | 13 | 2019 | 4348 | 0.640 |
Why?
|
| Phthalazines | 1 | 2019 | 263 | 0.590 |
Why?
|
| Proto-Oncogene Proteins c-akt | 9 | 2011 | 2075 | 0.560 |
Why?
|
| Gene Amplification | 1 | 2019 | 767 | 0.550 |
Why?
|
| Phosphatidylinositol 3-Kinases | 8 | 2019 | 1711 | 0.550 |
Why?
|
| Gonanes | 3 | 2011 | 50 | 0.540 |
Why?
|
| Morpholines | 2 | 2019 | 296 | 0.490 |
Why?
|
| Aminopyridines | 2 | 2019 | 223 | 0.480 |
Why?
|
| Cell Line, Tumor | 22 | 2021 | 14808 | 0.450 |
Why?
|
| Adenine | 1 | 2017 | 668 | 0.450 |
Why?
|
| Enzyme Inhibitors | 5 | 2018 | 1948 | 0.440 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2014 | 101 | 0.440 |
Why?
|
| Cell Cycle Proteins | 3 | 2019 | 2121 | 0.440 |
Why?
|
| DNA Damage | 3 | 2021 | 1986 | 0.440 |
Why?
|
| Oxidative Stress | 1 | 2019 | 1149 | 0.440 |
Why?
|
| Neoplastic Stem Cells | 4 | 2021 | 1459 | 0.430 |
Why?
|
| Apoptosis | 9 | 2018 | 7763 | 0.410 |
Why?
|
| Ependymoma | 2 | 2011 | 265 | 0.400 |
Why?
|
| Receptors, Notch | 1 | 2014 | 372 | 0.370 |
Why?
|
| Nuclear Proteins | 3 | 2018 | 3446 | 0.360 |
Why?
|
| Cell Proliferation | 12 | 2021 | 7250 | 0.350 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2018 | 1839 | 0.350 |
Why?
|
| Transcription Factor AP-1 | 2 | 2010 | 249 | 0.350 |
Why?
|
| Blood-Brain Barrier | 2 | 2024 | 249 | 0.340 |
Why?
|
| Disease Models, Animal | 5 | 2024 | 7383 | 0.320 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2019 | 5407 | 0.320 |
Why?
|
| NF-kappa B | 3 | 2006 | 1563 | 0.320 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2019 | 3907 | 0.320 |
Why?
|
| Mice | 23 | 2024 | 35624 | 0.310 |
Why?
|
| Piperazines | 1 | 2017 | 2144 | 0.300 |
Why?
|
| Blotting, Western | 7 | 2017 | 3596 | 0.300 |
Why?
|
| Animals | 27 | 2024 | 62190 | 0.280 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2007 | 133 | 0.280 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2007 | 1586 | 0.270 |
Why?
|
| Carrier Proteins | 4 | 2017 | 2101 | 0.270 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2022 | 3669 | 0.260 |
Why?
|
| Tetrazoles | 1 | 2006 | 96 | 0.260 |
Why?
|
| Down-Regulation | 3 | 2009 | 2091 | 0.250 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2006 | 126 | 0.250 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2005 | 258 | 0.240 |
Why?
|
| Phosphatidylinositol 3-Kinase | 2 | 2019 | 84 | 0.240 |
Why?
|
| Tumor Cells, Cultured | 12 | 2011 | 5762 | 0.240 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2013 | 1282 | 0.230 |
Why?
|
| Enzyme Activation | 8 | 2019 | 1815 | 0.230 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2006 | 550 | 0.220 |
Why?
|
| Phosphoproteins | 2 | 1998 | 1138 | 0.220 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 2 | 2004 | 58 | 0.210 |
Why?
|
| Cell Division | 8 | 2005 | 2678 | 0.210 |
Why?
|
| Phosphotyrosine | 1 | 2002 | 125 | 0.200 |
Why?
|
| Phosphorylation | 7 | 2018 | 4950 | 0.200 |
Why?
|
| Endothelial Growth Factors | 1 | 2002 | 231 | 0.200 |
Why?
|
| Lymphokines | 1 | 2002 | 313 | 0.190 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2021 | 9041 | 0.190 |
Why?
|
| Antineoplastic Agents | 4 | 2019 | 14628 | 0.190 |
Why?
|
| Cell Cycle | 7 | 2021 | 2142 | 0.180 |
Why?
|
| ErbB Receptors | 4 | 2022 | 2379 | 0.180 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2019 | 4961 | 0.180 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2019 | 2614 | 0.170 |
Why?
|
| Genes, Tumor Suppressor | 7 | 2002 | 1127 | 0.170 |
Why?
|
| Humans | 45 | 2021 | 270903 | 0.170 |
Why?
|
| Immunoenzyme Techniques | 2 | 2011 | 1196 | 0.160 |
Why?
|
| Receptor, TIE-2 | 1 | 2019 | 78 | 0.160 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2002 | 659 | 0.160 |
Why?
|
| Spheroids, Cellular | 1 | 2019 | 217 | 0.160 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2011 | 1126 | 0.160 |
Why?
|
| CDC2 Protein Kinase | 1 | 2019 | 188 | 0.160 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 2 | 2021 | 512 | 0.160 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2019 | 185 | 0.150 |
Why?
|
| Aurora Kinase A | 1 | 2019 | 210 | 0.150 |
Why?
|
| RNA, Messenger | 6 | 2013 | 6417 | 0.150 |
Why?
|
| Telomerase | 1 | 2021 | 547 | 0.150 |
Why?
|
| Conserved Sequence | 1 | 1998 | 497 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 7 | 2021 | 3217 | 0.140 |
Why?
|
| Heterografts | 1 | 2019 | 742 | 0.140 |
Why?
|
| Proteomics | 1 | 2024 | 1428 | 0.140 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2017 | 285 | 0.140 |
Why?
|
| Neovascularization, Pathologic | 2 | 2004 | 1586 | 0.140 |
Why?
|
| Up-Regulation | 4 | 2019 | 2425 | 0.140 |
Why?
|
| Computational Biology | 2 | 2021 | 1279 | 0.130 |
Why?
|
| Transfection | 7 | 2008 | 3119 | 0.130 |
Why?
|
| Transglutaminases | 2 | 2008 | 99 | 0.130 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2013 | 617 | 0.130 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2016 | 89 | 0.130 |
Why?
|
| Genes, Reporter | 4 | 2007 | 820 | 0.130 |
Why?
|
| Serine | 2 | 2006 | 392 | 0.120 |
Why?
|
| Cell Growth Processes | 1 | 2014 | 337 | 0.110 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 3022 | 0.110 |
Why?
|
| Chromosome Breakage | 1 | 2013 | 225 | 0.110 |
Why?
|
| Protease Inhibitors | 1 | 2014 | 207 | 0.100 |
Why?
|
| beta Catenin | 1 | 2016 | 689 | 0.100 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2013 | 189 | 0.100 |
Why?
|
| Gene Expression Profiling | 4 | 2016 | 5150 | 0.100 |
Why?
|
| RNA, Small Interfering | 2 | 2022 | 2198 | 0.100 |
Why?
|
| Transcription, Genetic | 4 | 2010 | 3345 | 0.100 |
Why?
|
| Male | 12 | 2019 | 128438 | 0.090 |
Why?
|
| Genes, Lethal | 1 | 2011 | 131 | 0.090 |
Why?
|
| Mucin 5AC | 1 | 2010 | 74 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 2 | 2005 | 1472 | 0.090 |
Why?
|
| Cell Movement | 4 | 2011 | 2476 | 0.090 |
Why?
|
| Pyridones | 1 | 2013 | 360 | 0.090 |
Why?
|
| Transcriptional Activation | 2 | 2007 | 1111 | 0.090 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 206 | 0.090 |
Why?
|
| Tissue Distribution | 1 | 2011 | 931 | 0.090 |
Why?
|
| Neural Stem Cells | 1 | 2011 | 183 | 0.090 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2011 | 563 | 0.080 |
Why?
|
| DNA Copy Number Variations | 2 | 2013 | 1554 | 0.080 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 625 | 0.080 |
Why?
|
| Cell Survival | 4 | 2016 | 3064 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 4 | 2005 | 4052 | 0.080 |
Why?
|
| Protein Kinase C | 1 | 2010 | 412 | 0.080 |
Why?
|
| Bile Acids and Salts | 1 | 2010 | 259 | 0.080 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 2 | 1998 | 88 | 0.080 |
Why?
|
| Organoplatinum Compounds | 1 | 2011 | 704 | 0.080 |
Why?
|
| Gene Expression | 6 | 2016 | 3650 | 0.080 |
Why?
|
| Prostatic Neoplasms | 2 | 2002 | 5854 | 0.080 |
Why?
|
| Binding Sites | 3 | 2002 | 2255 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2005 | 1579 | 0.070 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 1206 | 0.070 |
Why?
|
| Esophagus | 1 | 2010 | 563 | 0.070 |
Why?
|
| GTP-Binding Proteins | 2 | 2008 | 342 | 0.070 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2008 | 163 | 0.070 |
Why?
|
| DNA-Binding Proteins | 5 | 2017 | 5020 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2002 | 1641 | 0.070 |
Why?
|
| Vitronectin | 1 | 2005 | 24 | 0.070 |
Why?
|
| Quinolines | 1 | 2009 | 400 | 0.070 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 1998 | 379 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2014 | 4153 | 0.060 |
Why?
|
| Organoselenium Compounds | 1 | 2005 | 7 | 0.060 |
Why?
|
| Gene Dosage | 1 | 2008 | 824 | 0.060 |
Why?
|
| Neoplasms | 3 | 2021 | 15893 | 0.060 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2006 | 135 | 0.060 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2006 | 161 | 0.060 |
Why?
|
| Threonine | 1 | 2005 | 164 | 0.060 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2006 | 154 | 0.060 |
Why?
|
| Adenocarcinoma | 2 | 2010 | 7920 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 1589 | 0.060 |
Why?
|
| Neoadjuvant Therapy | 1 | 2019 | 5224 | 0.060 |
Why?
|
| Fibronectins | 1 | 2005 | 207 | 0.060 |
Why?
|
| G2 Phase | 1 | 2005 | 218 | 0.060 |
Why?
|
| Microbubbles | 1 | 2024 | 17 | 0.060 |
Why?
|
| Disease Progression | 4 | 2019 | 6841 | 0.060 |
Why?
|
| Receptor, PAR-1 | 1 | 2004 | 32 | 0.060 |
Why?
|
| Pyrimidines | 2 | 2017 | 3662 | 0.060 |
Why?
|
| Cysteine | 1 | 2005 | 213 | 0.060 |
Why?
|
| Ultrasonic Therapy | 1 | 2024 | 57 | 0.060 |
Why?
|
| Epidermal Growth Factor | 1 | 2006 | 439 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2005 | 634 | 0.060 |
Why?
|
| Luciferases | 2 | 2002 | 460 | 0.060 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2004 | 177 | 0.060 |
Why?
|
| Imidazoles | 1 | 2009 | 1059 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 3617 | 0.050 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2005 | 237 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2005 | 142 | 0.050 |
Why?
|
| Anticarcinogenic Agents | 1 | 2005 | 368 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2005 | 524 | 0.050 |
Why?
|
| fas Receptor | 1 | 2004 | 197 | 0.050 |
Why?
|
| Epithelial Cells | 2 | 2010 | 1872 | 0.050 |
Why?
|
| Kinetics | 2 | 2004 | 2221 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 1527 | 0.050 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2022 | 76 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2002 | 246 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 4 | 2 | 2013 | 210 | 0.050 |
Why?
|
| Sequence Analysis, Protein | 1 | 2002 | 80 | 0.050 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2001 | 33 | 0.050 |
Why?
|
| Poly ADP Ribosylation | 1 | 2021 | 9 | 0.050 |
Why?
|
| Anoikis | 1 | 2001 | 63 | 0.050 |
Why?
|
| Biomarkers, Tumor | 4 | 2013 | 10702 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2002 | 399 | 0.050 |
Why?
|
| Enzyme Assays | 1 | 2021 | 24 | 0.050 |
Why?
|
| Catalytic Domain | 1 | 2002 | 306 | 0.050 |
Why?
|
| Retroviridae | 1 | 2001 | 373 | 0.050 |
Why?
|
| Adenoviridae | 2 | 2004 | 1492 | 0.050 |
Why?
|
| Guanine | 1 | 2021 | 157 | 0.050 |
Why?
|
| DNA Modification Methylases | 1 | 2021 | 174 | 0.050 |
Why?
|
| Telomere Homeostasis | 1 | 2021 | 77 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 10366 | 0.050 |
Why?
|
| RNA | 2 | 2005 | 1065 | 0.040 |
Why?
|
| src-Family Kinases | 1 | 2003 | 488 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2021 | 181 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2001 | 895 | 0.040 |
Why?
|
| DNA Repair Enzymes | 1 | 2021 | 235 | 0.040 |
Why?
|
| Sequence Deletion | 2 | 2002 | 909 | 0.040 |
Why?
|
| Plasmids | 1 | 2001 | 936 | 0.040 |
Why?
|
| Genes, p53 | 1 | 2004 | 1143 | 0.040 |
Why?
|
| Pyridazines | 1 | 2022 | 319 | 0.040 |
Why?
|
| Agglutinins | 1 | 1999 | 16 | 0.040 |
Why?
|
| Radiation Tolerance | 2 | 2017 | 636 | 0.040 |
Why?
|
| Dimethyl Suberimidate | 1 | 1998 | 2 | 0.040 |
Why?
|
| Arabidopsis Proteins | 1 | 1999 | 52 | 0.040 |
Why?
|
| Dacarbazine | 1 | 2021 | 503 | 0.040 |
Why?
|
| Chromatography, Affinity | 1 | 1998 | 144 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 1998 | 329 | 0.040 |
Why?
|
| Plant Proteins | 1 | 1999 | 133 | 0.040 |
Why?
|
| RNA, Antisense | 1 | 1998 | 78 | 0.040 |
Why?
|
| Dimerization | 1 | 1998 | 311 | 0.040 |
Why?
|
| Potassium Channels | 1 | 1999 | 195 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 1998 | 167 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 880 | 0.040 |
Why?
|
| DNA | 2 | 2022 | 3056 | 0.040 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2021 | 607 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 1007 | 0.040 |
Why?
|
| Quinazolines | 1 | 2022 | 956 | 0.040 |
Why?
|
| Culture Media | 1 | 1998 | 347 | 0.040 |
Why?
|
| Doxorubicin | 2 | 2004 | 3143 | 0.040 |
Why?
|
| Drug Synergism | 2 | 2011 | 1360 | 0.040 |
Why?
|
| Glutathione Transferase | 1 | 1998 | 367 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 5080 | 0.040 |
Why?
|
| Multigene Family | 1 | 1998 | 465 | 0.040 |
Why?
|
| Acrosome | 1 | 1996 | 15 | 0.030 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2008 | 1824 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 552 | 0.030 |
Why?
|
| Time Factors | 2 | 2019 | 13023 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2016 | 1566 | 0.030 |
Why?
|
| Drug Combinations | 2 | 2011 | 635 | 0.030 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1996 | 116 | 0.030 |
Why?
|
| Antigens | 1 | 1996 | 280 | 0.030 |
Why?
|
| Membrane Proteins | 2 | 2004 | 2927 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 1996 | 309 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2017 | 693 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2011 | 17041 | 0.030 |
Why?
|
| Infant | 1 | 2011 | 13970 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2004 | 4959 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2001 | 1544 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2004 | 1932 | 0.030 |
Why?
|
| Survival Rate | 4 | 2013 | 12515 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 1998 | 1030 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 1999 | 1052 | 0.030 |
Why?
|
| Spermatogenesis | 1 | 1996 | 332 | 0.030 |
Why?
|
| Phenotype | 2 | 2004 | 6494 | 0.030 |
Why?
|
| DNA Replication | 1 | 2017 | 773 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2017 | 1830 | 0.030 |
Why?
|
| Oligodendrocyte Transcription Factor 2 | 1 | 2013 | 22 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 2477 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2016 | 1071 | 0.030 |
Why?
|
| Proteins | 2 | 2004 | 2046 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 7100 | 0.030 |
Why?
|
| Peptides | 1 | 1998 | 1505 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 3350 | 0.030 |
Why?
|
| Nitrates | 1 | 1992 | 46 | 0.030 |
Why?
|
| Nitrites | 1 | 1992 | 68 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 4568 | 0.030 |
Why?
|
| Protein Stability | 1 | 2013 | 378 | 0.020 |
Why?
|
| Female | 6 | 2019 | 148813 | 0.020 |
Why?
|
| Protein Binding | 1 | 1998 | 3486 | 0.020 |
Why?
|
| Gene Fusion | 1 | 2013 | 214 | 0.020 |
Why?
|
| Fibroblasts | 1 | 1998 | 1658 | 0.020 |
Why?
|
| Cytokines | 1 | 2001 | 2817 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2013 | 252 | 0.020 |
Why?
|
| Centrosome | 1 | 2011 | 106 | 0.020 |
Why?
|
| Bile Reflux | 1 | 2010 | 7 | 0.020 |
Why?
|
| Saliva | 1 | 1992 | 238 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2019 | 3987 | 0.020 |
Why?
|
| Cell Line | 1 | 1998 | 5344 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 2 | 2005 | 884 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2008 | 5249 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2013 | 522 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2010 | 264 | 0.020 |
Why?
|
| Boronic Acids | 1 | 2011 | 355 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2013 | 528 | 0.020 |
Why?
|
| Bortezomib | 1 | 2011 | 544 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2013 | 757 | 0.020 |
Why?
|
| DNA Repair | 1 | 2017 | 1911 | 0.020 |
Why?
|
| Algorithms | 1 | 2021 | 3921 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2013 | 815 | 0.020 |
Why?
|
| Entropy | 1 | 2008 | 36 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 681 | 0.020 |
Why?
|
| Drug Design | 1 | 2011 | 371 | 0.020 |
Why?
|
| Adult | 3 | 2019 | 81883 | 0.020 |
Why?
|
| Pyrazines | 1 | 2011 | 511 | 0.020 |
Why?
|
| Mutation | 3 | 2004 | 15904 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2011 | 1030 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2000 | 2431 | 0.020 |
Why?
|
| Esophageal Neoplasms | 2 | 2010 | 3241 | 0.020 |
Why?
|
| Carcinoma | 1 | 1999 | 2611 | 0.020 |
Why?
|
| Models, Biological | 1 | 2016 | 3202 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2001 | 5442 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2013 | 1002 | 0.020 |
Why?
|
| Melanoma | 1 | 2004 | 5596 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2011 | 1989 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2013 | 1186 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2008 | 592 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2004 | 5566 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 1468 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2008 | 692 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2004 | 2460 | 0.020 |
Why?
|
| Rats | 2 | 2010 | 6556 | 0.020 |
Why?
|
| Selenocysteine | 1 | 2005 | 2 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2008 | 664 | 0.020 |
Why?
|
| Insulin | 1 | 2011 | 1487 | 0.020 |
Why?
|
| Prognosis | 3 | 2013 | 22495 | 0.020 |
Why?
|
| Chitinase-3-Like Protein 1 | 1 | 2005 | 17 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 2347 | 0.020 |
Why?
|
| Barrett Esophagus | 1 | 2010 | 560 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2009 | 903 | 0.020 |
Why?
|
| TNF Receptor-Associated Factor 1 | 1 | 2004 | 8 | 0.020 |
Why?
|
| Lectins | 1 | 2005 | 148 | 0.020 |
Why?
|
| Okadaic Acid | 1 | 2004 | 31 | 0.020 |
Why?
|
| Autophagy | 1 | 2011 | 910 | 0.010 |
Why?
|
| Adipokines | 1 | 2005 | 96 | 0.010 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2004 | 38 | 0.010 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2004 | 138 | 0.010 |
Why?
|
| Genetic Vectors | 2 | 2000 | 1857 | 0.010 |
Why?
|
| Laminin | 1 | 2004 | 211 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2004 | 248 | 0.010 |
Why?
|
| Brefeldin A | 1 | 2004 | 22 | 0.010 |
Why?
|
| Celecoxib | 1 | 2004 | 198 | 0.010 |
Why?
|
| Ribonucleases | 1 | 2004 | 97 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2004 | 207 | 0.010 |
Why?
|
| I-kappa B Proteins | 1 | 2004 | 177 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2004 | 279 | 0.010 |
Why?
|
| Transcription Factor RelA | 1 | 2004 | 184 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 344 | 0.010 |
Why?
|
| Caspase 8 | 1 | 2004 | 146 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2003 | 58 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 2004 | 153 | 0.010 |
Why?
|
| I-kappa B Kinase | 1 | 2004 | 248 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2013 | 6231 | 0.010 |
Why?
|
| Breast Neoplasms | 2 | 2004 | 16213 | 0.010 |
Why?
|
| Carcinogens | 1 | 2004 | 391 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2004 | 475 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2008 | 7726 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 939 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 417 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2003 | 190 | 0.010 |
Why?
|
| 5' Flanking Region | 1 | 2002 | 21 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2004 | 1077 | 0.010 |
Why?
|
| Transcription Initiation Site | 1 | 2002 | 48 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2004 | 591 | 0.010 |
Why?
|
| Genomics | 1 | 2013 | 2825 | 0.010 |
Why?
|
| E2F2 Transcription Factor | 1 | 2001 | 27 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2004 | 591 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2013 | 9303 | 0.010 |
Why?
|
| E2F4 Transcription Factor | 1 | 2001 | 30 | 0.010 |
Why?
|
| Collagen | 1 | 2004 | 727 | 0.010 |
Why?
|
| E2F Transcription Factors | 1 | 2001 | 137 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2004 | 12022 | 0.010 |
Why?
|
| Astrocytes | 1 | 2005 | 407 | 0.010 |
Why?
|
| Caspases | 1 | 2004 | 679 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2005 | 782 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2004 | 742 | 0.010 |
Why?
|
| Genes, bcl-2 | 1 | 2001 | 172 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2003 | 1719 | 0.010 |
Why?
|
| E2F1 Transcription Factor | 1 | 2001 | 199 | 0.010 |
Why?
|
| Genome, Human | 1 | 2008 | 1885 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2004 | 810 | 0.010 |
Why?
|
| Adenoviruses, Human | 1 | 2000 | 191 | 0.010 |
Why?
|
| Stomach Neoplasms | 1 | 1992 | 2322 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 1097 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 31000 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2001 | 804 | 0.010 |
Why?
|
| Brain | 1 | 2011 | 4227 | 0.010 |
Why?
|
| Middle Aged | 3 | 2019 | 90230 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 3029 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 3070 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 1999 | 624 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 1999 | 629 | 0.010 |
Why?
|
| Transgenes | 1 | 1998 | 577 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2005 | 5718 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 1999 | 547 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2004 | 1539 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1996 | 596 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 1999 | 907 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 2571 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2004 | 5309 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1999 | 2313 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1999 | 1964 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 73259 | 0.010 |
Why?
|
| Sampling Studies | 1 | 1992 | 170 | 0.010 |
Why?
|
| India | 1 | 1992 | 313 | 0.010 |
Why?
|
| Vaccination | 1 | 1996 | 1155 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2004 | 14006 | 0.010 |
Why?
|
| Diet | 1 | 1992 | 1483 | 0.000 |
Why?
|
| Age Factors | 1 | 1992 | 5487 | 0.000 |
Why?
|
| Adolescent | 1 | 1992 | 32723 | 0.000 |
Why?
|
| Child | 1 | 1992 | 30550 | 0.000 |
Why?
|